The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2256-2260

  Linderholm, Barbro K ^a   Lindahl, Thomas ^a   Holmberg, Lars ^b   Klaar, Sigrid ^a   Lennerstrand, Johan ^d   Henriksson, Roger ^c   Bergh, Jonas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d Virco UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; MUTANT PROTEIN; PROTEIN P53; TAMOXIFEN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CORRELATION FUNCTION; DNA SEQUENCE; ENZYME IMMUNOASSAY; GENE DELETION; GENE INSERTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STOP CODON;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035266296     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Induction of angiogenesis during the transition from hyperplasia to neoplasia
2. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
3. Growth factors in development, transformation, and tumor genesis
4. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
5. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
6. Angiogenic factors
7. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
8. Tumors: Wounds that do not heal
9. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
10. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
11. 165) is of high prognostic value in node-negative breast carcinoma
12. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients
13. Correlation of vascular endothelial growth factor (VEGF) content with recurrences, survival, and first relapse-site in node-positive breast cancer following adjuvant systemic treatment
14. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
15. p53 as an independent marker of in lymph node-negative breast cancer patients
16. Prognostic significance of p53 gene alterations in node-negative breast cancer
17. Prognostic significance of TP53 alterations in breast carcinoma
18. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
19. Prognostic significance of p53 overexpression in primary breast cancer: A novel luminometric immunoassay applicable on steroid receptor cytosols
20. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
21. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-I
22. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
23. Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors
24. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial
25. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
26. The prognostic value and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers
27. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
28. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53
29. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas
30. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy
31. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
32. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
33. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
34. Down regulation of transforming growth factor-α by tamoxifen in human breast cancer
35. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes
36. A simulation study of the number of events per variable in logistic regression analysis
37. Determination of angiogenesis adds information to estrogen receptor status in predicting efficacy of adjuvant tamoxifen in node-positive patients